» Articles » PMID: 37488084

[Research Progress on the Protective Effect of Intestinal Flora on 
Radiation-induced Lung Injury in Thoracic Tumors]

Overview
Date 2023 Jul 24
PMID 37488084
Authors
Affiliations
Soon will be listed here.
Abstract

Radiation therapy is one of the main treatment methods for patients with thoracic malignant tumors, which can effectively improve the survival rate of the patients. However, radiation therapy can also cause damage to normal tissues while treating tumors, leading to radiation-induced lung injury such as radiation pneumonia and pulmonary fibrosis. Radiation-induced lung injury is a complex pathophysiological process involving many factors, and its prevention and treatment is one of the difficult problems in the field of radiation medicine. Therefore, the search for sensitive predictors of radiation-induced lung injury can guide clinical radiotherapy and reduce the incidence of radiation-induced lung injury. With the in-depth study of intestinal flora, it can drive immune cells or metabolites to reach lung tissue through the circulatory system to play a role, and participate in the occurrence, development and treatment of lung diseases. At present, there are few studies on intestinal flora and radiation-induced lung injury. Therefore, this paper will comprehensively elaborate the interaction between intestinal flora and radiation-induced lung injury, so as to provide a new direction and strategy for studying the protective effect of intestinal flora on radiation-induced lung injury.
.

References
1.
Li W, Deng Y, Chu Q, Zhang P . Gut microbiome and cancer immunotherapy. Cancer Lett. 2019; 447:41-47. DOI: 10.1016/j.canlet.2019.01.015. View

2.
Nie X, Li L, Yi M, Qin W, Zhao W, Li F . The Intestinal Microbiota Plays as a Protective Regulator Against Radiation Pneumonitis. Radiat Res. 2020; 194(1):52-60. DOI: 10.1667/RR15579.1. View

3.
Dracham C, Mahajan R, Rai B, Elangovan A, Bhattacharya T, Ghoshal S . Toxicity and clinical outcomes with definitive three-dimensional conformal radiotherapy (3DCRT) and concurrent cisplatin chemotherapy in locally advanced cervical carcinoma. Jpn J Clin Oncol. 2018; 49(2):146-152. DOI: 10.1093/jjco/hyy164. View

4.
Parashar B, Edwards A, Mehta R, Pasmantier M, Wernicke A, Sabbas A . Chemotherapy significantly increases the risk of radiation pneumonitis in radiation therapy of advanced lung cancer. Am J Clin Oncol. 2010; 34(2):160-4. DOI: 10.1097/COC.0b013e3181d6b40f. View

5.
Pinkerton J, Kim R, Robertson A, Hirota J, Wood L, Knight D . Inflammasomes in the lung. Mol Immunol. 2017; 86:44-55. DOI: 10.1016/j.molimm.2017.01.014. View